(1994a) Low-dose estrogen replacement therapy for Alzheimer's disease in women. Menopause, 1: 125-130.Ohkura T, Isse K, Alazawa K, Hamamoto M, Yaoi Y, Hagino N: Low-dose estrogen replacement therapy for Alzheimer's dis- ease in women. Menopause 1994; 1:125-130...
Conclusion: Flaxseed + low-dose estrogen therapy provides the greatest protection against ovariectomy-induced bone loss at the lumbar vertebrae. Moreover, this study is the first to demonstrate that flaxseed, rich in alpha-linolenic acid, alters fatty acid composition in the ovariectomized rat ...
These results suggest that there is an additive effect of low dose estrogen and calcium on bone resorption, but not on bone formation, in older women. Thus, the combination of low dose estrogen plus calcium is likely to be more effective in older women than either treatment alone. 展开 ...
Effects of low dose estrogen replacement therapy on bone and lipid metabolism in Japanese postmenopausal womenAbstract Without Abstractdoi:10.1007/BF02500464T. NakamoraJ. T. ChenT. HoriuchiJ. InoueH. OrimoSpringer-VerlagOsteoporosis International
Cardioprotection by Low-dose of Estrogen and Testosterone at the Physiological Ratio on Ovariectomized Rats During Ischemia/Reperfusion Injury. Although estrogen and testosterone deficiency have often been associated with the development of cardiac diseases in postmenopausal women, the benefits of ... L Fu...
Better bones: Women benefit from low dose of estrogenNo abstract is available for this article.doi:10.2307/3982057Nathan SeppaJohn Wiley & Sons, Ltd.Science News
but not proven, that the risk of breast cancer in women taking hormone replacement therapy is related to the dose of estrogen exposure over time. The interrupted progestogen regimen used in the present invention is not likely to enhance estrogenic effects in the breast, since progestogen does not...
It is believed, but not proven, that the risk of breast cancer in women taking hormone replacement therapy is related to the dose of estrogen exposure over time. [0014] Despite substantial efforts made to date, there remains a need for improved HRT regimens that minimize estrogen exposure, ...
athe frequency of VTE diagnosis ranges between 7 - 10 per 10,000 woman years in low estrogen dose (< 50 µg ethinylestradiol) COC users. VTE诊断范围频率在7 - 10之间每10,000妇女年在低女性荷尔蒙药量 (< 50名µg ethinylestradiol) COC用户。[translate]...
OBJECTIVE: To investigate the changes of BMD (bone mineral density), biochemical bone markers and lipid profiles after combination therapy of low dose estrogen (0.3 mg) and intermittent fluoride (monofluorophosphate) in postmenopausal osteopenia. METHOD: We studied 61 women with postmenopausal osteopenia...